(Q37679209)

21 August 2017

1 reference

title

Residual risk for secondary ischemic events in patients with atherothrombotic disease: opportunity for future improvements in patient care (English)

1 reference

21 August 2017

1 reference

Carl J Pepine

1

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

21 August 2017

1 reference

21 August 2017

volume

42

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

19-35

1 reference

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Randomized trial of lifestyle modification and pharmacotherapy for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

The role of oral antiplatelet agents in atherothrombotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Ethnic-specific prevalence of peripheral arterial disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Mortality over a period of 10 years in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascul

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Beyond unfractionated heparin and warfarin: current and future advances

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Pathophysiology of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Platelet activation and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Cell adhesion mechanisms in platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Thrombin and platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

A revised model of platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Platelets in inflammation and atherogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Platelets: inflammatory firebugs of vascular walls

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Role of Toll like receptor signaling pathway in ischemic coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Rosuvastatin in older patients with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Observational studies of statins in systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Telmisartan to prevent recurrent stroke and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Long-term follow-up after tight control of blood pressure in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Oral anticoagulant and antiplatelet therapy and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

New oral anticoagulants in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Effect of torcetrapib on the progression of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Simvastatin with or without ezetimibe in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Effects of torcetrapib in patients at high risk for coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Cytochrome p-450 polymorphisms and response to clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Genetic determinants of response to clopidogrel and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Biomarkers of atherosclerosis: clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Coronary Calcification, Coronary Disease Risk Factors, C-Reactive Protein, and Atherosclerotic Cardiovascular Disease Events

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Screening patients with chest pain in the emergency department using electron beam tomography: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Impact of aortic stiffness on survival in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Aortic stiffness is an independent predictor of fatal stroke in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Left ventricular hypertrophy and clinical outcomes in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

One-year cardiovascular event rates in outpatients with atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

Arterial Stiffness and Risk of Coronary Heart Disease and Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring by Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903260898

10.3109/07853890903260898

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference